Cystotech ApS: Financial statements 2025
CVR: 42773565
Cystotech ApS (CVR 42773565) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,528,137 and a net result of DKK -4,382,149 compared with DKK -3,454,057 the year before. That is an increase of 74.2% compared with the year before. Equity amounted to DKK 24,841,030. The solvency ratio was 77.2%. The company had 10 employees in the financial year.
- Gross Profit
- 1,528,137 kr.
- Profit/Loss
- -4,382,149 kr.
- Equity
- 24,841,030 kr.
- Total Assets
- 32,169,271 kr.
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.5 mio. | -4.4 mio. | 24.8 mio. | 10 |
| 2024 | - | 877 t. | -3.5 mio. | 9.5 mio. | 4 |
| 2023 | - | 1.6 mio. | -1.6 mio. | 7.6 mio. | 4 |
Find more companies like Cystotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of October 1, 2025, Anna Munk Nielsen is registered as director of Cystotech ApS.
As of September 30, 2025, Jacob Elmose Jensen has stepped down as director of Cystotech ApS.
Cystotech ApS has published its annual report for 2024. Gross profit came to DKK 877,328, and the net result was DKK -3,454,057.
As of March 12, 2025, Cystotech Invest II ApS is registered as an owner of Cystotech ApS with an ownership share of 5%.
About Cystotech ApS
Cystotech ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Hansen and Anna Munk Nielsen. The company's owners include CH MEDINVEST ApS, Den Midtjyske Iværksætterfond and h6capital ApS. In 2025, the company reported a gross profit of DKK 1,528,137 and a net result of DKK -4,382,149 compared with DKK -3,454,057 the year before. Equity amounted to DKK 24,841,030.
